NM_002485.5:c.283G>A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_002485.5(NBN):​c.283G>A​(p.Asp95Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00226 in 1,614,012 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D95H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0023 ( 4 hom. )

Consequence

NBN
NM_002485.5 missense

Scores

2
11
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:20O:1

Conservation

PhyloP100: 4.11

Publications

34 publications found
Variant links:
Genes affected
NBN (HGNC:7652): (nibrin) Mutations in this gene are associated with Nijmegen breakage syndrome, an autosomal recessive chromosomal instability syndrome characterized by microcephaly, growth retardation, immunodeficiency, and cancer predisposition. The encoded protein is a member of the MRE11/RAD50 double-strand break repair complex which consists of 5 proteins. This gene product is thought to be involved in DNA double-strand break repair and DNA damage-induced checkpoint activation. [provided by RefSeq, Jul 2008]
NBN Gene-Disease associations (from GenCC):
  • Nijmegen breakage syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Orphanet, ClinGen
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • idiopathic aplastic anemia
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.02321592).
BP6
Variant 8-89981412-C-T is Benign according to our data. Variant chr8-89981412-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 127869.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00183 (279/152300) while in subpopulation NFE AF = 0.0031 (211/68022). AF 95% confidence interval is 0.00276. There are 0 homozygotes in GnomAd4. There are 116 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002485.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NBN
NM_002485.5
MANE Select
c.283G>Ap.Asp95Asn
missense
Exon 3 of 16NP_002476.2
NBN
NM_001024688.3
c.37G>Ap.Asp13Asn
missense
Exon 4 of 17NP_001019859.1A0A0C4DG07
NBN
NM_001440379.1
c.37G>Ap.Asp13Asn
missense
Exon 3 of 16NP_001427308.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NBN
ENST00000265433.8
TSL:1 MANE Select
c.283G>Ap.Asp95Asn
missense
Exon 3 of 16ENSP00000265433.4O60934
NBN
ENST00000697309.1
c.283G>Ap.Asp95Asn
missense
Exon 3 of 15ENSP00000513244.1A0A8V8TKY5
NBN
ENST00000697293.1
c.283G>Ap.Asp95Asn
missense
Exon 3 of 17ENSP00000513230.1A0A8V8TM80

Frequencies

GnomAD3 genomes
AF:
0.00183
AC:
279
AN:
152182
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000627
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00310
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00173
AC:
435
AN:
251380
AF XY:
0.00172
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.000607
Gnomad ASJ exome
AF:
0.00407
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000370
Gnomad NFE exome
AF:
0.00295
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.00231
AC:
3373
AN:
1461712
Hom.:
4
Cov.:
31
AF XY:
0.00224
AC XY:
1627
AN XY:
727148
show subpopulations
African (AFR)
AF:
0.000388
AC:
13
AN:
33472
American (AMR)
AF:
0.000738
AC:
33
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00429
AC:
112
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39676
South Asian (SAS)
AF:
0.000359
AC:
31
AN:
86250
European-Finnish (FIN)
AF:
0.000375
AC:
20
AN:
53402
Middle Eastern (MID)
AF:
0.000695
AC:
4
AN:
5754
European-Non Finnish (NFE)
AF:
0.00275
AC:
3054
AN:
1111916
Other (OTH)
AF:
0.00176
AC:
106
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
170
339
509
678
848
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00183
AC:
279
AN:
152300
Hom.:
0
Cov.:
32
AF XY:
0.00156
AC XY:
116
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.000626
AC:
26
AN:
41562
American (AMR)
AF:
0.000588
AC:
9
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00576
AC:
20
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.000377
AC:
4
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00310
AC:
211
AN:
68022
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
14
28
42
56
70
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00288
Hom.:
1
Bravo
AF:
0.00182
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00256
AC:
22
ExAC
AF:
0.00186
AC:
226
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00333
EpiControl
AF:
0.00308

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
7
not provided (8)
-
1
5
Microcephaly, normal intelligence and immunodeficiency (6)
-
-
5
not specified (6)
-
-
3
Hereditary cancer-predisposing syndrome (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
22
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.59
D
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Uncertain
0.89
D
M_CAP
Uncertain
0.093
D
MetaRNN
Benign
0.023
T
MetaSVM
Uncertain
0.49
D
MutationAssessor
Pathogenic
3.3
M
PhyloP100
4.1
PrimateAI
Benign
0.46
T
PROVEAN
Uncertain
-4.3
D
REVEL
Uncertain
0.58
Sift
Uncertain
0.012
D
Sift4G
Uncertain
0.040
D
Polyphen
1.0
D
Vest4
0.59
MVP
0.87
MPC
0.40
ClinPred
0.063
T
GERP RS
4.8
PromoterAI
-0.017
Neutral
Varity_R
0.61
gMVP
0.70
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61753720; hg19: chr8-90993640; COSMIC: COSV104545419; API